Effect of Fludrocortisone on Intradialytic Hypotension: An Open-Label, Randomized, Crossover Study (vol 52, pg 264, 2023)

被引：0
|
作者：
不详
机构：
来源：
BLOOD PURIFICATION | 2024年 / 53卷 / 05期
关键词：
D O I：
10.1159/000538354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [1] Effect of Fludrocortisone on Intradialytic Hypotension: An Open-Label, Randomized, Crossover Study
    Vongchaiudomchoke, Thanawat
    Siriyong, Patchanon
    Wachiraphansakul, Nuttaya
    Noppakun, Kajohnsak
    BLOOD PURIFICATION, 2023, 52 (03) : 264 - 274
  • [2] THE EFFECT OF CILNIDIPINE ON INTRADIALYTIC BLOOD PRESSURE IN INTRADIALYTIC HYPERTENSIVE PATIENTS: A MULTICENTER, PROSPECTIVE, RANDOMIZED, OPEN-LABEL STUDY
    Ito, Takayasu
    Fujimoto, Naoki
    Ishikawa, Eiji
    Dohi, Kaoru
    Kiyohara, Michiyo
    Takeuchi, Hideyuki
    Koyabu, Sukenari
    Nishimura, Hiroyuki
    Takeuchi, Toshiaki
    Ito, Masaaki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [3] A Randomized, Open-Label, Crossover Study Evaluating the Effect of Food on the Relative Bioavailability of Linagliptin in Healthy Subjects
    Graefe-Mody, Ulrike
    Giessmann, Thomas
    Ring, Arne
    Iovino, Mario
    Woerle, Hans-Juergen
    CLINICAL THERAPEUTICS, 2011, 33 (08) : 1096 - 1103
  • [4] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
    Preskorn, Sheldon
    Ereshefsky, Larry
    Chiu, Yu-Yuan
    Poola, Nagaraju
    Loebel, Antony
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
  • [5] Effects of Intradialytic Parenteral Nutrition on Blood Glucose in Patients on Maintenance Hemodialysis: A Multicenter, Randomized, Open-Label Study
    Tani, Miyuki
    Hosojima, Michihiro
    Kabasawa, Hideyuki
    Kanda, Eiichiro
    Nagai, Miho
    Murayama, Toshiko
    Kamoshita, Satoru
    Kuroda, Akiyoshi
    Kanno, Yoshihiko
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [6] Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
    Wang, Yanli
    Deng, Qiaohuan
    Gao, Zhenyue
    Liu, Guangwen
    Su, Zhengjie
    Zhao, Yicheng
    Zhang, Lixiu
    Yang, Haimiao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] An Open-Label, Randomized, Two-Period Crossover Study of the NuvaRing Applicator in Healthy Women
    Feldman, Robert
    Frenkl, Tara
    Yacik, Carol
    Wang, Yinna
    Fox, Michelle
    OBSTETRICS AND GYNECOLOGY, 2016, 127 : 116S - 116S
  • [8] Comparison of valsartan and irbesartan in the treatment of mild to moderate hypertension: A randomized, open-label, crossover study
    Malacco, E
    Piazza, S
    Meroni, R
    Milanesi, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (11): : 789 - 797
  • [9] A randomized, open-label, crossover study examining the effect of injection site on bioavallability of exenatide (synthetic exendin-4)
    Calara, F
    Taylor, K
    Han, J
    Zabala, E
    Carr, EM
    Wintle, M
    Fineman, M
    CLINICAL THERAPEUTICS, 2005, 27 (02) : 210 - 215
  • [10] The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants (vol 37, pg 745, 2020)
    Chen, Joseph
    Xu, Huiping
    Pawlak, Sylvester
    James, Leonard P.
    Peltz, Gerson
    Lee, Kimberly
    Ginman, Katherine
    Bergeron, Michelle
    Pithavala, Yazdi K.
    ADVANCES IN THERAPY, 2020, 37 (11) : 4754 - 4754
12345